Due Diligence Checklist
Life Sciences Due Diligence Checklist
What’s Hot and What’s Not in IO 2021?
Oncology venture funding, IPOs and partnerships have been exceptionally high in deal volume and values. Cancer continues to be the leading therapeutic area in the number and size of early deals, and the oncology pipeline continues to be a rich source of both follow-on agents as well as first-in-class programs.
Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public?
Practical Application of Artificial Intelligence in Drug Discovery and Development
The Seven Habits of Highly Effective Data Rooms
Essential Steps to Successful Biopharma Partnering
Valuation of Your Early Drug Candidate
Preparing Your Company for the M&A Process
The Art & Science of High M&A Valuation
Best Practices for Fundraising and M&A Due Diligence
This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more.